Estimated GFR Trajectories of People Entering CKD Stage 4 and Subsequent Kidney Disease Outcomes and Mortality
- PMID: 26948835
- DOI: 10.1053/j.ajkd.2016.02.039
Estimated GFR Trajectories of People Entering CKD Stage 4 and Subsequent Kidney Disease Outcomes and Mortality
Abstract
Background: Estimated glomerular filtration rate (eGFR) trajectories of people entering chronic kidney disease (CKD) stage 4 and their associations with subsequent kidney disease outcomes or death are not known.
Study design: Longitudinal observational cohort study.
Setting & participants: 26,246 patients in the Veterans Affairs Healthcare System who entered CKD stage 4 in fiscal year 2008 followed up until October 2013.
Factors: 5-year eGFR trajectories, demographic and health characteristics.
Outcomes: Composite kidney disease outcome of kidney failure, dialysis therapy or transplantation, and death.
Results: Latent class group modeling and functional characterization suggest the presence of 3 distinct trajectory classes: class 1 (72%), consistent slow decline with absolute eGFR change of -2.45 (IQR, -3.89 to -1.16) mL/min/1.73m(2) per year; class 2 (18%), consistent fast decline and eGFR change of -8.60 (IQR, -11.29 to -6.66) mL/min/1.73m(2) per year; and class 3 (10%), early nondecline and late fast decline with eGFR change of -0.4mL/min/1.73m(2) per year in years 1 to 3 and -7.98 and -21.36mL/min/1.73m(2) per year in years 4 and 5, respectively. During 4.34 years of follow-up, 9,809 (37%) patients had the composite kidney disease outcome and 14,550 (55%) patients died. Compared to the referent group (trajectory class 1), HRs for 1-year risk for composite kidney disease outcome for trajectory classes 2 and 3 were 1.13 (95% CI, 1.05-1.22) and 0.67 (95% CI, 0.59-0.75), whereas HRs for 1-year risk for death for classes 2 and 3 were 1.17 (95% CI, 1.10-1.28) and 1.29 (95% CI, 1.18-1.42), respectively. The 1-year risk for composite kidney disease outcome was 32% and was 42% more likely than the risk for death in trajectory classes 1 and 2, respectively, whereas the risk for death was 67% more likely than the risk for composite kidney disease outcome in trajectory class 3.
Limitations: Inclusion criteria and mostly male participants limit generalizability of study results.
Conclusions: We characterized 3 different eGFR trajectory classes of people entering CKD stage 4. Our results suggest that the pattern of eGFR trajectory informs the risk for kidney disease outcomes and death.
Keywords: Chronic kidney disease (CKD); comorbid conditions; concordant; dialysis; discordant; disease progression; eGFR trajectories; end-stage renal disease (ESRD); estimated glomerular filtration rate (eGFR); kidney disease outcomes; kidney failure; kidney function trajectory; mortality; rate of kidney function decline; renal function trajectory; renal outcomes; stage 4 CKD; transplant; viral infections.
Published by Elsevier Inc.
Similar articles
-
Associations Between Weight Loss, Kidney Function Decline, and Risk of ESRD in the Chronic Kidney Disease in Children (CKiD) Cohort Study.Am J Kidney Dis. 2018 May;71(5):648-656. doi: 10.1053/j.ajkd.2017.08.013. Epub 2017 Nov 11. Am J Kidney Dis. 2018. PMID: 29132947 Free PMC article.
-
Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.Am J Kidney Dis. 2014 Feb;63(2):236-43. doi: 10.1053/j.ajkd.2013.08.028. Epub 2013 Oct 30. Am J Kidney Dis. 2014. PMID: 24182662 Free PMC article.
-
Receipt of Nephrology Care and Clinical Outcomes Among Veterans With Advanced CKD.Am J Kidney Dis. 2017 Nov;70(5):705-714. doi: 10.1053/j.ajkd.2017.06.025. Epub 2017 Aug 12. Am J Kidney Dis. 2017. PMID: 28811048 Free PMC article.
-
Kidney and Cardiovascular Outcomes Among Patients With CKD Receiving GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomized Trials.Am J Kidney Dis. 2025 May;85(5):555-569.e1. doi: 10.1053/j.ajkd.2024.11.013. Epub 2025 Jan 23. Am J Kidney Dis. 2025. PMID: 39863261
-
GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration.Am J Kidney Dis. 2014 Dec;64(6):821-35. doi: 10.1053/j.ajkd.2014.07.030. Epub 2014 Oct 16. Am J Kidney Dis. 2014. PMID: 25441437 Review.
Cited by
-
Costs Associated With Progression of Mildly Reduced Kidney Function Among Medicare Advantage Enrollees.Kidney Med. 2023 Mar 30;5(6):100636. doi: 10.1016/j.xkme.2023.100636. eCollection 2023 Jun. Kidney Med. 2023. PMID: 37250500 Free PMC article.
-
Markers and risk factors for chronic kidney disease in sub-Saharan Africans: baseline levels and 12-month trajectories in newly referred patients in Cameroon.BMC Nephrol. 2020 Mar 18;21(1):101. doi: 10.1186/s12882-020-01760-6. BMC Nephrol. 2020. PMID: 32188410 Free PMC article.
-
Discrepant glomerular filtration rate trends from creatinine and cystatin C in patients with chronic kidney disease: results from the KNOW-CKD cohort.BMC Nephrol. 2020 Jul 16;21(1):280. doi: 10.1186/s12882-020-01932-4. BMC Nephrol. 2020. PMID: 32677901 Free PMC article.
-
Decline of kidney function during the pre-dialysis period in chronic kidney disease patients: a systematic review and meta-analysis.Clin Epidemiol. 2018 May 25;10:613-622. doi: 10.2147/CLEP.S153367. eCollection 2018. Clin Epidemiol. 2018. PMID: 29872350 Free PMC article.
-
Semiparametric joint modeling to estimate the treatment effect on a longitudinal surrogate with application to chronic kidney disease trials.Biometrics. 2025 Jul 3;81(3):ujaf104. doi: 10.1093/biomtc/ujaf104. Biometrics. 2025. PMID: 40758454
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous